THE ENDEAVOUR PRACTICE — All Prescriptions & Medications — Page 4
Practice Code: A81023 | MIDDLESBROUGH, TS1 2NX
Showing results 151-200 of 540
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Lymecycline | 203 | 7,546 | £867 | +68.8% ▲ |
| Temazepam | 201 | 2,408 | £2.1K | +251.4% ▲ |
| Quinine sulfate | 200 | 5,691 | £698 | -30.9% ▼ |
| Glyceryl trinitrate | 199 | 796 | £544 | -15.9% ▼ |
| Cyclizine hydrochloride | 199 | 13.9K | £622 | +23.4% ▲ |
| 198 | 24.2K | £1.8K | +51.1% ▲ | |
| Lactulose | 197 | 121.8K | £1.1K | -40.2% ▼ |
| 193 | 201 | £252 | -12.4% ▼ | |
| Edoxaban | 192 | 4,725 | £7.9K | -72.6% ▼ |
| Progesterone | 192 | 16.4K | £3.3K | -54.1% ▼ |
| Lercanidipine hydrochloride | 188 | 6,244 | £674 | -69.6% ▼ |
| Hydroxocobalamin | 181 | 216 | £463 | -62.4% ▼ |
| Memantine hydrochloride | 179 | 3,834 | £658 | -45.8% ▼ |
| Piroxicam | 175 | 16.8K | £438 | +204.6% ▲ |
| Ibuprofen | 174 | 15.5K | £499 | +42.8% ▲ |
| Clobetasol propionate | 174 | 8,405 | £912 | +27.5% ▲ |
| Loratadine | 167 | 7,424 | £215 | -20.1% ▼ |
| Letrozole | 167 | 5,292 | £488 | -10.6% ▼ |
| Cefalexin | 166 | 7,160 | £502 | +42.7% ▲ |
| Methenamine hippurate | 163 | 7,720 | £1.8K | +79.2% ▲ |
| Tolterodine | 163 | 6,272 | £734 | +9.6% ▲ |
| Clotrimazole | 160 | 3,770 | £220 | +65.1% ▲ |
| Topiramate | 159 | 10.1K | £1.3K | -10.5% ▼ |
| 159 | 1,234 | £609 | -36.3% ▼ | |
| Clarithromycin | 158 | 3,247 | £721 | -35.6% ▼ |
| Estradiol | 158 | 3,495 | £1.9K | -41.4% ▼ |
| Etoricoxib | 155 | 5,208 | £1.2K | +92.4% ▲ |
| Calcipotriol | 155 | 15.2K | £8.2K | -9.0% ▼ |
| Vortioxetine | 154 | 2,590 | £2.4K | +121.9% ▲ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 154 | 693.4K | £13.7K | +120.1% ▲ |
| Trimethoprim | 152 | 4,922 | £258 | -25.6% ▼ |
| Lofepramine hydrochloride | 149 | 6,489 | £2.8K | +398.1% ▲ |
| Pravastatin sodium | 145 | 4,312 | £198 | -55.3% ▼ |
| Medroxyprogesterone acetate | 144 | 233 | £1.4K | +19.3% ▲ |
| Hypromellose | 143 | 1,920 | £609 | +7.9% ▲ |
| Mesalazine (Systemic) | 142 | 13.1K | £7.1K | -40.7% ▼ |
| Canagliflozin | 142 | 4,800 | £6.0K | -1.1% vs avg |
| Estriol | 141 | 2,614 | £1.9K | -33.7% ▼ |
| Dexamethasone | 140 | 725 | £452 | -18.6% ▼ |
| Glycopyrronium/formoterol | 139 | 139 | £4.3K | +449.5% ▲ |
| Lithium carbonate | 138 | 4,477 | £658 | +8.8% ▲ |
| Beclometasone dipropionate | 138 | 138 | £409 | -35.8% ▼ |
| Chloramphenicol | 137 | 940 | £550 | +19.6% ▲ |
| Estradiol with progestogen | 136 | 9,136 | £3.5K | -60.1% ▼ |
| Nebivolol | 131 | 4,146 | £745 | +23.6% ▲ |
| Clobazam | 131 | 5,641 | £2.2K | +98.7% ▲ |
| Carbomer 940/980 | 131 | 3,180 | £650 | -14.0% ▼ |
| Sacubitril/valsartan | 129 | 6,202 | £10.1K | -46.1% ▼ |
| Buspirone hydrochloride | 129 | 5,593 | £1.1K | +156.1% ▲ |
| Ketoconazole | 129 | 16.6K | £2.6K | +31.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.